The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2024

Filed:

May. 31, 2018
Applicant:

Amplio Pharma Ab, Lund, SE;

Inventors:
Assignee:

AMPLIO PHARMA AB, Lund, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/529 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/7048 (2006.01); A61P 19/02 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/0053 (2013.01); A61K 9/0095 (2013.01); A61K 9/20 (2013.01); A61K 31/7048 (2013.01); A61P 19/02 (2018.01);
Abstract

The present invention relates to a pharmaceutical product comprising a combination of methotrexate and novobiocin, or any pharmaceutically acceptable salts of said compounds, and a pharmaceutical composition comprising (i) a therapeutic amount of methotrexate or any pharmaceutically acceptable salts thereof, and one or more pharmaceutically acceptable excipient, carrier or diluent, (ii) a non-therapeutic amount of novobiocin or any pharmaceutically acceptable salts thereof, and one or more pharmaceutically acceptable excipient, carrier or diluent. The invention further relates to a use of the pharmaceutical product and composition in therapy, such as prevention, progression prophylaxis and/or treatment of autoimmune diseases.


Find Patent Forward Citations

Loading…